TickerFactsScreenerDevelopers

Royalty Pharma plc (RPRX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2018: $1.36B2019: $2.62B2020: $1.60B2021: $1.43B2022: $307.06M2023: $1.49B2024: $1.29B2025: $1.56B$1.56B
2018Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025$1.56B+20.7%
2024$1.29B-13.4%
2023$1.49B+385.9%
2022$307.06M-78.5%
2021$1.43B-10.3%
2020$1.60B-39.2%
2019$2.62B+92.3%
2018$1.36B—